SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for Cryoport, Inc. (CYRX) (CIK 0001124524) (CYRX) — Sep 19, 2017

Cryoport, Inc. (CYRX) (CIK 0001124524)
Date: Sept. 19, 2017 · CIK: 0001124524 · Accession: 0000000000-17-033117

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-203006

Date
September 18, 2017
Author
/s/ Laura Nicholson
Form
UPLOAD
Company
Cryoport, Inc. (CYRX) (CIK 0001124524)

Letter

Mail Stop 3561 September 18, 2017 Robert Stefanovich Chief Financial Officer Cryoport, Inc. 17305 Daimler Street Irvine, CA 92614

Re: Cryoport, Inc. Post-Effective Amendment to Form S-1 on Form S -3 Filed August 31, 2017 File No. 333-203006

Dear Mr. Stefanovich :

We have reviewed your post-effective amendment and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure.

Please respond to this letter by amending your registration statement and providing the requested information . If you do not believe our comments apply to your facts and circumstances or do not believe an amendme nt is appropriate, please tell us why in your response.

After reviewing any amendment to your registration statement and the information you provide in response to these comments, we may have additional comments.

General

1. Please clarify in the explanatory note the relationship between this filing and the registration statement on Form S -1 (333 -212364) declared effective August 10, 2016. For example, please clarify in the explanatory note that you are continuing the registration of the offer and sale of the 1,640,401 shares of common stock issuable upon exercise of the remaining outstanding warrants pursuant to this post -effective amendment on Form S -3 (File No. 333 -203006) , and not pursuant to the registration statement on Form S -1 (333 -212364). Please also clarify in the explanatory note that the secondary offering included in the Form S -1 (333 -212364) declared effective August 10, 2016 has been terminated and you are concurrently filing a post -effective amendment to deregister unsold securitie s from that offering.

Robert Stefanovich Cryoport, Inc. September 18, 2017 Page 2

2. Please disclose on the prospectus cover and in Plan of Distribution that Feltl and Company, Inc., is an underwriter within the meaning of Securities Act Section 2(a)(11).

We remind you that the company and its management are respo nsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact J. Nolan McWilliams, Attorney -Advisor, at (202) 551 -3217 or me at (202) 551-3584 with any questions you may have .

Sincerely,
/s/ Laura Nicholson

Show Raw Text
Mail Stop 3561
September 18, 2017

Robert Stefanovich
Chief Financial Officer
Cryoport, Inc.
17305 Daimler Street
Irvine, CA 92614

Re: Cryoport, Inc.
 Post-Effective Amendment to Form  S-1 on Form S -3
Filed  August 31, 2017
 File No.  333-203006

Dear Mr. Stefanovich :

We have reviewed your  post-effective amendment  and have the following comments.  In
some of our comments, we may ask you to provide us with information so we may better
understand your disclosure.

Please respond to this letter by amending your registration statement  and providing the
requested information .  If you do not believe our comments apply to your facts and
circumstances or do not believe an amendme nt is appropriate, please tell us why in your
response.

After reviewing any amendment to your registration statement and the information you
provide in response to these  comments, we may have  additional comments.

General

1. Please clarify in the explanatory note the relationship between this filing and the
registration statement on Form S -1 (333 -212364) declared effective August 10, 2016.
For example, please clarify in the explanatory note that you are continuing the
registration of the offer and  sale of the 1,640,401 shares of common stock issuable upon
exercise of the remaining outstanding warrants pursuant to this post -effective amendment
on Form S -3 (File No. 333 -203006) , and not pursuant to the registration statement on
Form S -1 (333 -212364).   Please also clarify in the explanatory note that the secondary
offering included in the Form S -1 (333 -212364) declared effective August 10, 2016 has
been terminated and you are concurrently filing a post -effective amendment to deregister
unsold securitie s from that offering.

Robert Stefanovich
Cryoport, Inc.
September 18, 2017
Page 2

 2. Please disclose on the prospectus cover and in Plan of Distribution that Feltl and
Company, Inc., is an underwriter within the meaning of Securities Act Section 2(a)(11).

We remind you that the company and its management are respo nsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

Please contact J. Nolan McWilliams, Attorney -Advisor, at (202) 551 -3217  or me at (202)
551-3584  with any questions  you may have .

Sincerely,

 /s/ Laura Nicholson

Laura Nicholson
Special Counsel
Office of Transportation and Leisure

cc: Anthony Ippolito, Esq.
 Snell & Wilmer LLP